{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T21:42:08Z","timestamp":1792618928511,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["NRF-2022M3H4A1A03067401"],"award-info":[{"award-number":["NRF-2022M3H4A1A03067401"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.biomaterials.2022.121841","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T20:40:15Z","timestamp":1664570415000},"page":"121841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity"],"prefix":"10.1016","volume":"290","author":[{"given":"Suah","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Kyu","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukyung","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanhee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwoong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Ik","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooram","family":"Um","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Yeol","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7919-188X","authenticated-orcid":false,"given":"Kwangmeyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.biomaterials.2022.121841_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121841_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"18","key":"10.1016\/j.biomaterials.2022.121841_bib3","article-title":"Mathematical prediction of clinical outcomes in advanced cancer patients treated with checkpoint inhibitor immunotherapy","volume":"6","author":"Butner Joseph","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2022.121841_bib4","doi-asserted-by":"crossref","unstructured":"Z. Xiao, Z. Su, S. Han, J. Huang, L. Lin, X. Shuai, Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-\u03baB inhibitor for antitumor immunotherapy, Sci. Adv. 6(6) eaay7785.","DOI":"10.1126\/sciadv.aay7785"},{"issue":"17","key":"10.1016\/j.biomaterials.2022.121841_bib5","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121841_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121841_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrclinonc.2017.88","article-title":"Monitoring immune-checkpoint blockade: response evaluation and biomarker development","volume":"14","author":"Nishino","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121841_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aau5240","article-title":"Pharmacological inhibition of \u03b2-catenin\/BCL9 interaction overcomes resistance to immune checkpoint blockades by modulating Treg cells","volume":"5","author":"Feng","year":"2019","journal-title":"Sci. Adv."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121841_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201908961","article-title":"Inhibition of immunosuppressive tumors by polymer-assisted inductions of immunogenic cell death and multivalent PD-L1 crosslinking","volume":"30","author":"Li","year":"2020","journal-title":"Adv. Funct. Mater."},{"issue":"7670","key":"10.1016\/j.biomaterials.2022.121841_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121841_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41589-018-0161-x","article-title":"HIP1R targets PD-L1 to lysosomal degradation to alter T cell\u2013mediated cytotoxicity","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Chem. Biol."},{"issue":"7670","key":"10.1016\/j.biomaterials.2022.121841_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121841_bib13","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41551-019-0375-6","article-title":"Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours","volume":"3","author":"Yao","year":"2019","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/j.biomaterials.2022.121841_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2019.12.049","article-title":"Multivalent HER2-binding polymer conjugates facilitate rapid endocytosis and enhance intracellular drug delivery","volume":"319","author":"Radford","year":"2020","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121841_bib15","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1038\/mt.2015.178","article-title":"Receptor crosslinking: a general method to trigger internalization and lysosomal targeting of therapeutic receptor:ligand complexes","volume":"23","author":"Moody","year":"2015","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121841_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2010.03.020","article-title":"Downregulation of EGFR by a novel multivalent nanobody-liposome platform","volume":"145","author":"Oliveira","year":"2010","journal-title":"J. Contr. Release"},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121841_bib17","doi-asserted-by":"crossref","first-page":"6778","DOI":"10.1021\/acs.jpcc.5b11059","article-title":"Nanoparticle multivalency directed shifting of cellular uptake mechanism","volume":"120","author":"Dalal","year":"2016","journal-title":"J. Phys. Chem. C"},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121841_bib18","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1021\/acs.nanolett.0c00953","article-title":"An avidity-based PD-L1 antagonist using nanoparticle-antibody conjugates for enhanced immunotherapy","volume":"20","author":"Bu","year":"2020","journal-title":"Nano Lett."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121841_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003041","article-title":"Biomimetic anti-PD-1 peptide-loaded 2D FePSe3 nanosheets for efficient photothermal and enhanced immune therapy with multimodal MR\/PA\/thermal imaging","volume":"8","author":"Fang","year":"2021","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121841_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s40425-019-0705-y","article-title":"Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy","volume":"7","author":"Liu","year":"2019","journal-title":"Journal for ImmunoTherapy of Cancer"},{"issue":"40","key":"10.1016\/j.biomaterials.2022.121841_bib21","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1002\/anie.201506225","article-title":"Blocking of the PD-1\/PD-L1 interaction by a D-peptide antagonist for cancer immunotherapy","volume":"54","author":"Chang","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2022.121841_bib22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.addr.2020.06.005","article-title":"Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers","volume":"157","author":"Fang","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7655","key":"10.1016\/j.biomaterials.2022.121841_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature22396","article-title":"PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity","volume":"545","author":"Gordon","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2022.121841_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.339281","article-title":"Imaging and quantifying analysis the binding behavior of PD-L1 at molecular resolution by atomic force microscopy","volume":"1191","author":"Qin","year":"2022","journal-title":"Anal. Chim. Acta"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121841_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41392-020-00254-z","article-title":"Identification of a hotspot on PD-L1 for pH-dependent binding by monoclonal antibodies for tumor therapy","volume":"5","author":"Liu","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2022.121841_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2019.06.009","article-title":"A study of the endocytosis mechanism and transendothelial activity of lung-targeted GALA-modified liposomes","volume":"307","author":"Santiwarangkool","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2022.121841_bib27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2022.121841_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2019.02.016","article-title":"Current strategies in extending half-lives of therapeutic proteins","volume":"301","author":"Zaman","year":"2019","journal-title":"J. Contr. Release"},{"issue":"32","key":"10.1016\/j.biomaterials.2022.121841_bib29","doi-asserted-by":"crossref","first-page":"11774","DOI":"10.1073\/pnas.1410626111","article-title":"Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells","volume":"111","author":"Kim","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121841_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121841_bib31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41571-020-0413-z","article-title":"Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors","volume":"17","author":"Galluzzi","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121841_bib32","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004811?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222004811?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:13:40Z","timestamp":1758906820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222004811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":32,"alternative-id":["S0142961222004811"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121841","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liposome-mediated PD-L1 multivalent binding promotes the lysosomal degradation of PD-L1 for T cell-mediated antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121841"}}